Open access
Sep 2026
Cost-Effectiveness Analysis of the Use of the Antihypertensive Drugs Candesartan and Ramipril in Hospitalized Patients with Heart Failure and Hypertension
It can be concluded that, based on the results of the cost-effectiveness analysis, ramipril therapy is more cost-effective than candesartan from both perspectives.
Dinda Herawati, Niken Luthfiyanti, Bagas Ardiyantoro
· Journal Pharmacopoeia · 0 citations